Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking BelataceptMichael T. Ou, Jacqueline Garonzik‐Wang, Brian J. Boyarsky et al.|Transplantation|2021Cited by 67
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipientsAndrew M. Hallett, Errol L. Bush, Allan B. Massie et al.|The Journal of Heart and Lung Transplantation|2021Cited by 65
Characterizing the landscape and impact of infections following kidney transplantationKyle R. Jackson, Jennifer D. Motter, Sunjae Bae et al.|American Journal of Transplantation|2020Cited by 63
Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning studyAllan B. Massie, Brian J. Boyarsky, William A. Werbel et al.|American Journal of Transplantation|2020Cited by 59
Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 PandemicSunjae Bae, Dorry L. Segev, Mara McAdams‐DeMarco et al.|Transplantation|2020Cited by 40